Green Planet Bioengineering Co. Ltd.OTC: GPLB

Green Planet Bio Engineering Co. Ltd. 6M 2026: Net loss $(16,849), EPS < $0.01— 10-Q Summary

· Issued by Green Planet Bioengineering Co. Ltd.

Green Planet Bio Engineering Co. Ltd. reported a consolidated net loss of $(16,849) for the six months ended June 30, 2026, versus a net loss of $(10,945) for the same period in 2025. Diluted loss per share for the six-month period was less than $0.01 in both years.

Financial Highlights

  • Net income (loss): $(16,849) for 6M ended June 30, 2026, versus $(10,945) for 6M ended June 30, 2025 (consolidated net loss, year-to-date).
  • Diluted earnings per share: less than $0.01 loss per share for 6M ended June 30, 2026, versus less than $0.01 for 6M ended June 30, 2025.

Business Highlights

  • Operational status: The company remains a public reorganized shell with no active business operations during the reporting periods.
  • Revenue & channels: No revenue-generating channels or sales activity were reported; expenses were limited to accounting and filing fees.
  • Funding & liquidity: Operational funding was provided by a related-party majority stockholder; future activities depend on securing investor funding.
  • Going concern & outlook: Management intends to pursue acquisitions or mergers when opportunities arise, but substantial doubt exists about near-term viability.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.